• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

胰腺上皮细胞病变中的p53和K-RAS改变

p53 and K-RAS alterations in pancreatic epithelial cell lesions.

作者信息

Kalthoff H, Schmiegel W, Roeder C, Kasche D, Schmidt A, Lauer G, Thiele H G, Honold G, Pantel K, Riethmüller G

机构信息

Abteilung Immunologie, Medizinische Klinik, Universität Hamburg, Germany.

出版信息

Oncogene. 1993 Feb;8(2):289-98.

PMID:8426738
Abstract

We have analysed the expression of p53 at the mRNA level, and extensively at the protein level by immunostaining, Western blotting, and ELISA measurements revealing a p53 increase in 8 out of 14 cell lines established from human pancreatic carcinomas. The mRNA levels closely paralleled the protein levels in most of the cell lines. Overexpression of p53 in tumor cells correlated with mutations in the p53 gene. Immunocytochemistry was also performed with tissue cryosections showing a nuclear p53 staining in 8 out of 12 exocrine, and 2 out of 2 endocrine tumors. In addition, nonmalignant peri-tumoral tissue specimens and cells derived from pancreatic juice of acute pancreatic patients were also positively stained. These findings may suggest functions of p53 in stress situations induced by acute inflammation or tissue regeneration. Genomic mutations in the tumor suppressor gene were associated with point mutations in either codon 12, 13 or 61 in the c-K-RAS oncogene in about two-thirds of cell lines. The frequent activations of a RAS oncogene in combination with mutations of a tumor suppressor gene are likely to contribute to the malignant phenotype of pancreatic adenocarcinomas.

摘要

我们分析了p53在mRNA水平的表达,并通过免疫染色、蛋白质印迹法和酶联免疫吸附测定法在蛋白质水平进行了广泛分析,结果显示,在从人胰腺癌建立的14个细胞系中,有8个细胞系的p53表达增加。在大多数细胞系中,mRNA水平与蛋白质水平密切平行。肿瘤细胞中p53的过表达与p53基因的突变相关。我们还对组织冷冻切片进行了免疫细胞化学分析,结果显示,在12个外分泌肿瘤中有8个、2个内分泌肿瘤中有2个出现细胞核p53染色。此外,急性胰腺炎患者胰腺周围的非恶性组织标本以及胰腺液来源的细胞也呈阳性染色。这些发现可能提示p53在急性炎症或组织再生诱导的应激情况下的功能。在大约三分之二的细胞系中,肿瘤抑制基因的基因组突变与c-K-RAS癌基因中密码子12、13或61的点突变相关。RAS癌基因的频繁激活与肿瘤抑制基因的突变相结合,可能导致胰腺腺癌的恶性表型。

相似文献

1
p53 and K-RAS alterations in pancreatic epithelial cell lesions.胰腺上皮细胞病变中的p53和K-RAS改变
Oncogene. 1993 Feb;8(2):289-98.
2
Molecular genetics of malignant insulinoma.恶性胰岛素瘤的分子遗传学
Anticancer Res. 1996 Jul-Aug;16(4A):1707-17.
3
p53, Ki-ras, and DNA ploidy in human pancreatic ductal adenocarcinomas.人胰腺导管腺癌中的p53、Ki-ras和DNA倍体
Lab Invest. 1996 Jan;74(1):279-89.
4
Human pancreatic carcinomas and cell lines reveal frequent and multiple alterations in the p53 and Rb-1 tumor-suppressor genes.人类胰腺癌及癌细胞系显示出p53和Rb-1肿瘤抑制基因频繁且多处发生改变。
Oncogene. 1992 Aug;7(8):1503-11.
5
The potential diagnostic use of K-ras codon 12 and p53 alterations in brush cytology from the pancreatic head region.胰腺头部区域刷检细胞学中K-ras密码子12和p53改变的潜在诊断用途。
J Pathol. 1998 Nov;186(3):247-53. doi: 10.1002/(SICI)1096-9896(1998110)186:3<247::AID-PATH179>3.0.CO;2-J.
6
K-ras and p53 mutations in hamster pancreatic ductal adenocarcinomas and cell lines.仓鼠胰腺导管腺癌及细胞系中的K-ras和p53突变
Am J Pathol. 1996 Oct;149(4):1333-9.
7
Concomitant point mutation of tumor suppressor gene p53 and oncogene c-N-ras in malignant neuroendocrine pancreatic tumor.恶性神经内分泌胰腺肿瘤中肿瘤抑制基因p53和癌基因c-N-ras的伴随点突变
Anticancer Res. 1996 Nov-Dec;16(6B):3761-6.
8
Ki-ras codon 12 point and P53 mutations: a molecular examination of the main tumor, liver, portal vein, peripheral arterial blood and para-aortic lymph node in pancreatic cancer.Ki-ras密码子12点突变和P53突变:胰腺癌主要肿瘤、肝脏、门静脉、外周动脉血及腹主动脉旁淋巴结的分子检测
Am J Gastroenterol. 2000 Aug;95(8):1939-45. doi: 10.1111/j.1572-0241.2000.02081.x.
9
p53 and Kirsten-ras mutations in human mesothelioma cell lines.人恶性间皮瘤细胞系中的p53和 Kirsten-ras 突变
Cancer Res. 1992 May 1;52(9):2610-5.
10
K-ras and p53 in pancreatic cancer: association with medical history, histopathology, and environmental exposures in a population-based study.胰腺癌中的K-ras和p53:一项基于人群的研究中与病史、组织病理学及环境暴露的关联
Cancer Epidemiol Biomarkers Prev. 2000 Nov;9(11):1223-32.

引用本文的文献

1
Selective epigenetic alterations in RNF43 in pancreatic exocrine cells from high-fat-diet-induced obese mice; implications for pancreatic cancer.高脂饮食诱导肥胖小鼠胰腺外分泌细胞中 RNF43 的选择性表观遗传改变;对胰腺癌的影响。
BMC Res Notes. 2024 Apr 15;17(1):106. doi: 10.1186/s13104-024-06757-0.
2
GP-2250, a novel anticancer agent, inhibits the energy metabolism, activates AMP-Kinase and impairs the NF-kB pathway in pancreatic cancer cells.GP-2250,一种新型抗癌剂,抑制胰腺癌细胞的能量代谢,激活 AMP 激酶并损害 NF-kB 通路。
J Cell Mol Med. 2023 Jul;27(14):2082-2092. doi: 10.1111/jcmm.17825. Epub 2023 Jun 30.
3
The histone deacetylase inhibitor M344 as a multifaceted therapy for pancreatic cancer.
组蛋白去乙酰化酶抑制剂 M344 作为一种多方面的胰腺癌治疗方法。
PLoS One. 2022 Sep 20;17(9):e0273518. doi: 10.1371/journal.pone.0273518. eCollection 2022.
4
Inhibition of invasive pancreatic cancer: restoring cell apoptosis by activating mitochondrial p53.抑制侵袭性胰腺癌:通过激活线粒体p53恢复细胞凋亡。
Am J Cancer Res. 2019 Feb 1;9(2):390-405. eCollection 2019.
5
Genetic Alterations of Periampullary and Pancreatic Ductal Adenocarcinoma: An Overview.壶腹周围和胰腺导管腺癌的基因改变:概述
Curr Genomics. 2018 Sep;19(6):444-463. doi: 10.2174/1389202919666180221160753.
6
Targeting the duality of cancer.针对癌症的双重性。
NPJ Precis Oncol. 2017;1. doi: 10.1038/s41698-017-0026-x. Epub 2017 Jun 22.
7
Erratum to: The UBC-40 Urothelial Bladder Cancer cell line index: a genomic resource for functional studies.《UBC - 40膀胱癌细胞系索引:功能研究的基因组资源》勘误
BMC Genomics. 2016 Oct 25;17(1):829. doi: 10.1186/s12864-016-3179-z.
8
Tris DBA palladium is highly effective against growth and metastasis of pancreatic cancer in an orthotopic model.三(二亚苄基丙酮)二钯对原位模型中胰腺癌的生长和转移具有高效的抑制作用。
Oncotarget. 2016 Aug 9;7(32):51569-51580. doi: 10.18632/oncotarget.10514.
9
SOX2 functions as a molecular rheostat to control the growth, tumorigenicity and drug responses of pancreatic ductal adenocarcinoma cells.SOX2作为一种分子变阻器,可控制胰腺导管腺癌细胞的生长、致瘤性和药物反应。
Oncotarget. 2016 Jun 7;7(23):34890-906. doi: 10.18632/oncotarget.8994.
10
Erratum to: The UBC-40 Urothelial Bladder Cancer Cell Line Index: a genomic resource for functional studies.《UBC - 40膀胱癌细胞系索引:功能研究的基因组资源》勘误
BMC Genomics. 2015 Nov 30;16(1):1019. doi: 10.1186/s12864-015-2227-4.